SYK · Stryker Corp
$339.21
-1.88 (-0.55%)
At close · Aug 14
Market Cap
$133.18B
Shares
383.57M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $21,401,495 |
| Spencer S. Stiles | Group President, Orthopaedics | $6,328,959 |
| J. Andrew Pierce | Group President, MedSurg and Neurotechnology | $6,323,107 |
| Preston Wells | CFO | $4,410,422 |
| Preston W. Wells | Vice President, Chief Financial Officer | $4,410,422 |
| Viju S. Menon | Group President, Global Quality and Operations | $4,235,809 |
| Glenn Boehnlein | Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer | $1,893,046 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $21,979,369 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $7,339,754 |
| Spencer S. Stiles | Group President, Orthopaedics | $6,759,339 |
| J. Andrew Pierce | Group President, MedSurg and Neurotechnology | $6,759,339 |
| Viju S. Menon | Group President, Global Quality and Operations | $4,589,506 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $20,767,847 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $6,841,484 |
| J. Andrew Pierce | Group President, MedSurg and Neurotechnology | $6,489,849 |
| Spencer S. Stiles | Group President, Orthopaedics | $6,487,347 |
| Viju S. Menon | Group President, Global Quality and Operations | $4,470,034 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $18,563,214 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $5,853,281 |
| J. Andrew Pierce | Group President, MedSurg and Neurotechnology | $5,742,877 |
| Spencer S. Stiles | Group President, Orthopaedics | $5,711,874 |
| Viju S. Menon | Group President, Global Quality and Operations | $3,677,925 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $16,359,898 |
| Timothy J. Scannell | Executive Advisor | $8,121,406 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $6,015,333 |
| J. Andrew Pierce | Group President, MedSurg and Neurotechnology | $5,262,126 |
| Spencer S. Stiles | Group President, Orthopaedics and Spine | $5,187,039 |
| Viju S. Menon | Group President, Global Quality and Operations | $4,259,466 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $13,317,032 |
| Timothy J. Scannell | Executive Advisor | $6,517,994 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $4,345,853 |
| Viju S. Menon | Group President, Global Quality and Operations | $2,973,487 |
| Robert S. Fletcher | Vice President, Chief Legal Officer | $2,236,675 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair, Chief Executive Officer and President | $14,974,829 |
| Timothy J. Scannell | Executive Advisor | $7,113,232 |
| Glenn Boehnlein | Vice President, Chief Financial Officer | $4,375,730 |
| Robert S. Fletcher | Vice President, Chief Legal Officer | $3,146,774 |
| Viju S. Menon | Group President, Global Quality and Operations | $3,025,199 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chair and CEO | $13,911,065 |
| Timothy J. Scannell | President and COO | $6,632,178 |
| Viju S. Menon | Group President, Global Quality and Operations | $4,394,186 |
| Glenn Boehnlein | Vice President, CFO | $3,788,573 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Kevin A. Lobo | Chairman and CEO | $14,005,086 |
| Timothy J. Scannell | President and COO | $4,659,062 |
| Glenn Boehnlein | Vice President, CFO | $3,141,202 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Emily Baculik | chief accounting officer | Appointed | 2026-05-20 |
| William E. Berry, Jr. | Vice President, Chief Accounting Officer | Retired | 2026-05-20 |
| Dylan Crotty | Group President, Orthopaedics | Appointed | 2025-12-04 |
| Spencer Stiles | President and Chief Operating Officer | Appointed | 2025-12-04 |
| Rajeev Suri | Director | Appointed | 2025-05-13 |
| Andrew K. Silvernail | Director | Appointed | 2025-05-13 |
| Lisa M. Skeete Tatum | Director | Appointed | 2025-05-13 |
| Ronda E. Stryker | Director | Appointed | 2025-05-13 |
| Emmanuel P. Maceda | Director | Appointed | 2025-05-13 |
| Rachel Ruggeri | Director | Appointed | 2025-05-13 |
| Sherilyn S. McCoy | Director | Appointed | 2025-05-13 |
| Kevin A. Lobo | Director | Appointed | 2025-05-13 |
| Giovanni Caforio, M.D. | Director | Appointed | 2025-05-13 |
| Mary K. Brainerd | Director | Appointed | 2025-05-13 |
| Allan Golston | member of the Board of Directors | Retired | 2025-02-10 |
| Preston W. Wells | Vice President, Chief Financial Officer | Appointed | 2025-01-28 |
| Glenn S. Boehnlein | Vice President, Chief Financial Officer | Retired | 2025-01-28 |
| Dr. Srikant Datar | member of the Board of Directors | Retired | 2023-12-08 |
Key facts
CIK
310764
CUSIP
863667101
13F (30d)
1980 filings
1931 filers
Visit website
Investor relations